search button
Open Access

In vivo and in vitro studies on the roles of p38 mitogen‑activated protein kinase and NADPH‑cytochrome P450 reductase in Alzheimer's disease

  • Authors:
    • Yunyi Yao
    • Jin‑Zhong Huang
    • Liang Chen
    • Yingqi Chen
    • Xianhong Li

  • View Affiliations

  • Published online on: September 22, 2017     https://doi.org/10.3892/etm.2017.5182
  • Pages: 4755-4760

  • Copyright: © Yao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Alzheimer's disease (AD) is a chronic neurodegenerative disease with an increasing morbidity rate. As one of the most important signaling pathways that responds to inflammation and degeneration, the p38 mitogen‑activated protein kinase (MAPK) signaling pathway is active in the cortexes of AD mice. At the cellular level the same effect can be observed with p38 MAPK when induced by amyloid β (Aβ)1‑42, a 42‑residue Aβ fragment. Inhibition of p38 MAPK in the present study protected SH‑SY5Y cells from the toxicity of Aβ1‑42, and alleviated the formation of senile plaques and cognitive impairment in AD mice. The expression of cytochrome P450 reductase (CPR) in the brains of mice with AD, in addition to Aβ1‑42‑treated SH‑SY5Y cells, also increased. However, the inhibition of CPR did not protect SH‑SY5Y cells from the toxicity of Aβ1‑42. The results of the present study suggest that p38 MAPK is a potential therapeutic target for the treatment of AD. In addition, the main enzyme that metabolizes drugs, CPR, could serve a more complex role in AD.
View Figures
View References

Related Articles

Journal Cover

November-2017
Volume 14 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Yao Y, Huang JZ, Chen L, Chen Y and Li X: In vivo and in vitro studies on the roles of p38 mitogen‑activated protein kinase and NADPH‑cytochrome P450 reductase in Alzheimer's disease. Exp Ther Med 14: 4755-4760, 2017.
APA
Yao, Y., Huang, J., Chen, L., Chen, Y., & Li, X. (2017). In vivo and in vitro studies on the roles of p38 mitogen‑activated protein kinase and NADPH‑cytochrome P450 reductase in Alzheimer's disease. Experimental and Therapeutic Medicine, 14, 4755-4760. https://doi.org/10.3892/etm.2017.5182
MLA
Yao, Y., Huang, J., Chen, L., Chen, Y., Li, X."In vivo and in vitro studies on the roles of p38 mitogen‑activated protein kinase and NADPH‑cytochrome P450 reductase in Alzheimer's disease". Experimental and Therapeutic Medicine 14.5 (2017): 4755-4760.
Chicago
Yao, Y., Huang, J., Chen, L., Chen, Y., Li, X."In vivo and in vitro studies on the roles of p38 mitogen‑activated protein kinase and NADPH‑cytochrome P450 reductase in Alzheimer's disease". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4755-4760. https://doi.org/10.3892/etm.2017.5182